Octagos Health raised over $43 million in a Series B funding led by Morgan Stanley Expansion Capital to advance AI-Driven Cardiac Device Monitoring.
Octagos Health raised over $43 million in a Series B funding led by Morgan Stanley Expansion Capital to advance AI-Driven Cardiac Device Monitoring.
07/09/24, 5:31 PM
Location
houstonMoney raised
$43 million
Industry
healthcare
Round Type
series b
Investors
Other Strategic Investors, Mucker Capital, Morgan Stanley Expansion Capital
Octagos Health, an industry-leading provider of AI-driven cardiac device monitoring solutions, announced a successful equity raise of over $43 million in investment capital. This funding will accelerate Octagos Health's mission to use artificial intelligence to revolutionize cardiac care and provide comprehensive patient monitoring services.
Company Info
Location
houston, texas, united states
Additional Info
Octagos Health is a leading provider of cardiac monitoring solutions, dedicated to improving patient outcomes through advanced technology and comprehensive monitoring services. The company's AI-driven platform offers continuous monitoring and data analysis for patients with implantable cardiac devices, enabling healthcare providers to make informed decisions and deliver timely care. Octagos Health's solutions are designed to seamlessly integrate with electronic health records and provide customizable reporting features, making it an essential tool for modern healthcare institutions.